Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03471377 · ClinicalTrials.gov registry record
Improving Planned Surgical Case Duration Accuracy by Leveraging the EHR and Predictive Modeling
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 683
- Enrollment target
NCT03471377: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT03471377 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 683 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03471377 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 683 participants
- Enrollment target
Study Summary
The investigators are studying the duration it takes surgeons to complete their respective surgical cases. The hospital hopes to improve the overall operating room scheduling accuracy from this project.
Primary Outcome
All Gynecology (GYN) and Colorectal (CRS) Surgeons at MSKCC will be included. To test the hypothesis that the developed surgical case duration prediction model compared to the current process of estimating surgical case durations, will show improved prediction accuracy, measured by mean absolute error.
Interventions
- OTHER standard scheduling process
- OTHER assigned a planned case duration value from predictive model
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 683 participants |
| Start Date | 2018-03-05 |
| Est. Completion | 2022-03-15 |
What the finished NCT03471377 record still lists
NCT03471377 is an observational study that tracks outcomes without assigning an intervention. The registered 683 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which standard scheduling process is the first listed.
NCT03471377 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03471377 about?
NCT03471377 is a clinical study titled "Improving Planned Surgical Case Duration Accuracy by Leveraging the EHR and Predictive Modeling". The investigators are studying the duration it takes surgeons to complete their respective surgical cases. The hospital hopes to improve the overall operating room scheduling accuracy from this project.
What is the current status of trial NCT03471377?
This trial is currently completed. The enrollment target is 683 participants. The study started on 2018-03-05. Estimated completion is 2022-03-15.
What interventions are being tested in trial NCT03471377?
The interventions under investigation include: standard scheduling process (OTHER), assigned a planned case duration value from predictive model (OTHER).
Who is sponsoring clinical trial NCT03471377?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06795087 · 684 participants
Discharge Medication Use Post-Operatively in GU Cancer Patients
- NCT05099770 · 685 participants · Phase 3
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
- NCT05880199 · 685 participants
BSGM to Evaluate Patients With GI Symptoms
- NCT05382559 · 681 participants · Phase 1
A Study of ASP3082 in Adults With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI